| Vol. 13.12 – 8 April, 2021 |
|
|
|
| Investigators developed an all-in-one Tet-on system that could regulate replication of oncolytic adenovirus. [Cancer Letters] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers analyzed human umbilical-cord-derived MSCs from 32 donors and revealed donor-dependent variations in two non-correlated properties; cell proliferation, and immune modulatory functions in vitro and in vivo, which might explain inconsistent clinical efficacies of MSCs. [Cell Death & Disease] |
|
|
|
| Scientists evaluated the safety and describe the clinical changes after IV administration of allogeneic human umbilical cord MSCs, in patients with bilateral pneumonia caused by COVID-19, complicated with severe acute respiratory distress syndrome, as compassionate treatment. [Aging and Disease] |
|
|
|
| Researchers investigated whether human amniotic epithelial cells transplantation has the therapeutic effects on the rat uterine scar following full-thickness injury. [Stem Cell Research & Therapy] |
|
|
|
| Investigators conducted a Phase I-II single arm, exploratory clinical trial from 2012 to 2016 in a single center. 15 patients aged from 1.9 to 16.4 years received an intrabone umbilical cord blood transplantation. [Bone Marrow Transplantation] |
|
|
|
| The authors found that p65 was activated during cellular senescence and inflammatory activation in human umbilical cord-derived MSCs. [International Journal of Molecular Sciences] |
|
|
|
| Scientists investigated ten different properties of these cells cultured under 21% and 5% oxygen concentrations. [Cells] |
|
|
|
| Investigators developed a protocol enabling a derivation of MSC subpopulation with increased expression of pluripotent and neural genes. [Cells] |
| |
|
|
|
| The authors discuss evidence on the ability of perinatal cells to inhibit B cell proliferation, impair B cell differentiation, and promote regulatory B cell formation. [International Journal of Molecular Sciences] |
|
|
|
|
| Athersys, Inc. announced that its partner HEALIOS K.K. has completed enrollment in the ONE-BRIDGE study in Japan evaluating MultiStem® in patients with acute respiratory distress syndrome (ARDS) caused by pneumonia. [Athersys, Inc] |
|
|
|
|
|
|
| University of Chicago – Chicago, Illinois, United States |
|
|
|
| American Association for Cancer Research – Boston, Massachusetts, United States |
|
|
|
| Moores Cancer Center – La Jolla, California, United States |
|
|
|
| University of Washington – Seattle, Washington, United States |
|
|
|
| The University of Iowa – Iowa City, Iowa, United States |
|
|
|
|